Grants paid by Foundation to Eradicate Duchenne Inc
EIN 71-0874241 · Alexandria, VA · Form 990, Schedule I · NTEE H80
Foundation to Eradicate Duchenne Inc of Alexandria, VA (EIN 71-0874241) reported 27 grants paid totaling $1,955,914 to 13 recipients in tax years 2020–2025, on Form 990, Schedule I. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$1,955,914
27 grants
Recipients
13
distinct organizations
Tax years
2020–2025
5 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2020 | 5 | $475,555 | — |
| 2022 | 5 | $413,062 | — |
| 2023 | 4 | $334,865 | — |
| 2024 | 6 | $322,308 | — |
| 2025 | 7 | $410,124 | — |
Top recipients
The 13 recipients receiving the most from Foundation to Eradicate Duchenne Inc, by grants paid, out of 13 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Children's National Medical Center 52-1654453 | A | Washington, DC | 4 | $440,846 | 2024 |
| University of Pittsburgh 25-0965591 | A | Pittsburgh, PA | 3 | $246,617 | 2025 |
| Research Foundation for Suny at Binghamton University 16-6053710 | A | Binghamton, NY | 2 | $233,700 | 2023 |
| Parent Project Muscular Dystrophy 31-1405490 | A | Washington, DC | 5 | $205,000 | 2025 |
| Research Foundation for Suny 14-1368361 | A | Binghampton, NY | 2 | $201,755 | 2024 |
| Children's Research Institute 52-1640403 | A | Washington, DC | 2 | $201,000 | 2025 |
| Virginia Commonwealth University 54-6001758 | A | Richmond, VA | 2 | $113,703 | 2024 |
| Emory University 58-0566256 | A | Atlanta, GA | 1 | $90,000 | 2020 |
| Binghamton University 14-6013200 | A | Binghamton, NY | 1 | $86,860 | 2025 |
| Osteogenesis Imperfecta Foundation 23-7076021 | A | Gaithersburg, MD | 2 | $50,000 | 2025 |
| Reveragen Biopharma Inc 26-3808415 | A | Rockville, MD | 1 | $47,852 | 2022 |
| Old Dominion University 54-6068198 | A | Norfolk, VA | 1 | $27,055 | 2025 |
| Trinds LLC 81-1603540 | A | Pittsburgh, PA | 1 | $11,526 | 2022 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 27 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Children's Research Institute Washington, DC | A | $101,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202621289349302057 |
| 2025 | Children's National Heart Center Washington, DC | A | $100,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202621289349302057 |
| 2025 | Binghamton University Binghamton, NY | A | $86,860 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202621289349302057 |
| 2025 | Parent Project Muscular Dystrophy Washington, DC | A | $50,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202621289349302057 |
| 2025 | Old Dominion University Norfolk, VA | A | $27,055 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202621289349302057 |
| 2025 | Osteogenesis Imperfecta Foundation Gaithersburg, MD | A | $25,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202621289349302057 |
| 2025 | University of Pittsburgh Pittsburgh, PA | A | $20,209 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202621289349302057 |
| 2024 | Research Foundation for Suny for the State Univeristy of New York Albany, NY | A | $162,308 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202511289349302851 |
| 2024 | Virginia Commonwealth University Richmond, VA | A | $75,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202511289349302851 |
| 2024 | Duchenne Research Richmond, VA | A | $38,703 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202511289349302851 |
| 2024 | Parent Project Muscular Dystrophy Washington, DC | A | $25,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202511289349302851 |
| 2024 | University of Pittsburgh Pittsburgh, PA | A | $11,300 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202511289349302851 |
| 2024 | Children's Research Institute Washington, DC | A | $9,997 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202511289349302851 |
| 2023 | Research Foundation for Suny at Binghamton University Binghamton, NY | A | $134,865 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202413199349316031 |
| 2023 | Children's National Medical Center Washington, DC | A | $125,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202413199349316031 |
| 2023 | Parent Project Muscular Dystrophy Washington, DC | A | $50,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202413199349316031 |
| 2023 | Osteogenesis Imperfecta Foundation Philadelphia, PA | A | $25,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202413199349316031 |
| 2022 | Children's National Medical Center Washington, DC | A | $204,849 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202333119349302038 |
| 2022 | Research Foundation for Suny at Binghamton University Binghamton, NY | A | $98,835 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202333119349302038 |
| 2022 | Parent Project Muscular Dystrophy Washington, DC | A | $50,000 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202333119349302038 |
| 2022 | Reveragen Biopharma Inc Rockville, MD | A | $47,852 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202333119349302038 |
| 2022 | Trinds LLC Pittsburgh, PA | A | $11,526 | paid | TO FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202333119349302038 |
| 2020 | University of Pittsburgh Pittsburgh, PA | A | $215,108 | paid | FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202103159349305380 |
| 2020 | Children's Research Institute Silver Spring, MD | A | $101,000 | paid | FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202103159349305380 |
| 2020 | Emory University Atlanta, GA | A | $90,000 | paid | FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202103159349305380 |
| 2020 | Research Foundation for Suny Binghampton, NY | A | $39,447 | paid | FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202103159349305380 |
| 2020 | Parent Project Muscular Dystrophy Hackensack, NJ | A | $30,000 | paid | FUND RESEARCH FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | 202103159349305380 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990 | 2025 | 2025-12-31 | not stated | 2025v4.1 | 202621289349302057 |
| 990 | 2024 | 2024-12-31 | not stated | 2024v5.1 | 202511289349302851 |
| 990 | 2023 | 2023-12-31 | not stated | 2023v5.1 | 202413199349316031 |
| 990 | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202333119349302038 |
| 990 | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202103159349305380 |
Derived from IRS Form 990 e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/710874241.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.